Mesothelioma Cancer Centers
St. Joseph Mercy Ann Arbor Cancer Center in Michigan offers state of the art cancer care to their patients. The teaching hospital was founded in 1911 by four Sisters of Mercy and began with a staff of only nine care providers. Since then the hospital, and cancer center within, has been named a Top 100 Hospital and provides patients with a multidisciplinary approach to cancer care, enabling the most postive outcomes.
St. Joseph Mercy Ann Arbor Cancer Center makes the most of a patient's time and schedules visits with multiple cancer specialists at one time, which can expediate creation of a treatment plan.
Not only can patients receive personalized care at the St. Joseph Mercy Ann Arbor Cancer Center but partnerships with neighboring centers creates a multitude of patient options. For instance, the most cutting-edge clinical trials may be added to the standard treatment modalities through the cancer centers partnership with the Mayo Clinic.
- Clinical Trials
- Cyberknife Radiosurgery
- da Vinci Robotic Surgery
- Medical Oncology
- Radiation Oncology
- Thoracic Malignancies
- Joint Commission on Accreditation of Healthcare Organizations
- American College of Surgeons Commision on Cancer Approved Program with Comendation
- Blue Cross Blue Shield of Michigan Oncology Care Program
- Designated by the National Cancer Institute as a Clinical Communty Oncology Program (CCOP)
Mesothelioma Clinical Trials at St. Joseph Mercy Ann Arbor Cancer Center
The following clinical trials are in progress or actively recruiting participants at St. Joseph Mercy Ann Arbor Cancer Center:
Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy
Conditions: Malignant Mesothelioma Last Updated: March 4, 2019 Status: Active, not recruiting
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Epithelioid Mesothelioma; Pleural Malignant Mesothelioma; Recurrent Malignant Mesothelioma; Sarcomatoid Mesothelioma Last Updated: January 16, 2019 Status: Active, not recruiting